#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	394	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1328	16.0	0	.	p	.	0	K29T	NONSYN	85	87	AAG	438	440	ACG	12;12;13	A;C;G	12;12;13	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1572	Escherichia_coli_EF_Tu	1230	67	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.1	255	9.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1572	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1544	49.4	1	SNP	p	R234F	1	.	.	700	702	TTC	1033	1035	TTC	90;89;85	T;T;C	89;88;84	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1572	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1544	49.4	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1333	1335	CGT	69;69;70	C;G;T	69;69;69	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1572	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1544	49.4	0	HET	.	.	.	C255T	.	255	255	C	588	588	C	54	C,T	31,23	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	1572	Escherichia_coli_EF_Tu	1230	1211	99.83	Escherichia_coli_EF_Tu.l15.c17.ctg.2	1544	49.4	0	HET	.	.	.	T999C	.	999	999	T	1332	1332	T	70	T,C	39,31	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	680	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l6.c4.ctg.1	1843	19.7	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1573	1575	AAA	10;9;9	A;A;A	10;9;9	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	670	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1758	20.0	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1332	1334	GAA	26;26;27	G;A;A	26;26;27	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	164	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	551	13.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	96	96	G	96	G	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	98	98	C	87	C	87	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	102	102	C	76	C	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	130	130	T	81	T	81	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	180	180	C	102	C	101	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	205	205	C	93	C,A	92,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	213	213	A	95	A	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	216	216	A	94	A	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	218	218	A	91	A	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	226	226	T	95	T	94	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	227	227	C	96	C	95	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	235	235	C	80	C	80	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	236	236	A	79	A	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	241	241	G	75	G	75	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	243	243	C	74	C	74	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	248	248	T	78	T	77	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	256	256	G	93	G	92	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	259	259	G	91	G	91	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	260	260	T	92	T,G	90,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	316	316	T	97	T	96	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	318	318	G	88	G	88	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	328	328	C	80	C	79	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	330	330	A	77	A,C	75,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	365	365	C	51	C	51	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	.1409C	INS	1409	1409	T	369	369	C	50	C	50	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	391	391	A	11	A	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	392	392	A	11	A	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	401	401	G	12	G	12	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	424	424	C	15	C	15	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	433	433	T	55	T	55	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	435	435	G	64	G	64	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	508	508	T	47	T	47	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	560	1918	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l6.c17.ctg.3	546	85.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	154	154	C	108	C	108	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	594	PmrB_1	1092	1092	99.08	PmrB_1.l15.c17.ctg.1	1616	19.6	0	.	p	.	0	H2R	NONSYN	4	6	CAT	291	293	CGT	18;19;19	C;G;T	18;19;19	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	594	PmrB_1	1092	1092	99.08	PmrB_1.l15.c17.ctg.1	1616	19.6	0	.	p	.	0	V30I	NONSYN	88	90	GTC	375	377	ATC	22;21;20	A;T;C	22;21;20	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	594	PmrB_1	1092	1092	99.08	PmrB_1.l15.c17.ctg.1	1616	19.6	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1134	1136	GGC	21;20;20	G;G;C	21;20;20	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	904	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2180	22.2	0	.	p	.	0	R8S	NONSYN	22	24	AGA	310	312	AGC	12;11;12	A;G;C	12;11;12	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	904	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2180	22.2	0	.	p	.	0	I142L	NONSYN	424	426	ATA	712	714	CTA	16;16;15	C;T;A	16;16;15	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	904	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2180	22.2	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1231	1233	CAA	31;31;31	C;A;A	31;30;31	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	904	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2180	22.2	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1330	1332	GGT	37;34;34	G;G;T	37;34;34	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	904	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2180	22.2	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1900	1902	GTT	20;20;19	G;T;T	20;20;18	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	352	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1626	11.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	627	629	GAA	9;8;8	G;A;A	9;8;8	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	352	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1626	11.7	0	.	p	.	0	M185T	NONSYN	553	555	ATG	807	809	ACC	9;9;9	A;C;C	9;9;9	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	352	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1626	11.7	0	.	p	.	0	S225T	NONSYN	673	675	TCC	927	929	ACT	11;11;11	A;C;T	11;11;11	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	352	PmrE	1167	1167	96.83	PmrE.l6.c30.ctg.1	1626	11.7	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1317	1319	ATC	6;7;6	A;T;C	6;7;6	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	510	PmrF	969	969	99.38	PmrF.l15.c4.ctg.1	1441	18.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	72	TEM_1+	858	411	99.03	TEM_1+.l6.c4.ctg.1	411	4.1	0	.	p	.	0	M127S	NONSYN	379	381	ATG	84	86	TCG	10;10;10	T,A;C,T;G	9,1;9,1;10	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	72	TEM_1+	858	411	99.03	TEM_1+.l6.c4.ctg.1	411	4.1	0	.	p	.	0	H162R	NONSYN	484	486	CAT	189	191	CGT	2;3;3	C;G;T	2;3;3	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	72	TEM_1+	858	113	99.12	TEM_1+.l6.c4.ctg.2	135	3.2	0	.	p	.	0	F19L	NONSYN	55	57	TTT	77	79	CTT	4;4;4	C;T;T	4;4;4	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	512	72	TEM_1+	858	102	99.02	TEM_1+.l6.c4.ctg.3	102	5.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1506	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3529	22.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	468	470	ATC	20;20;20	A;T;C	20;20;20	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	1506	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3529	22.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2181	2183	AAG	19;19;18	A;A;G	19;19;18	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	522	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1640	16.9	0	.	p	.	0	A22V	NONSYN	64	66	GCC	284	286	GTC	10;10;10	G;T;C	10;10;10	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	522	acrE	1158	1158	98.79	acrE.l6.c4.ctg.1	1640	16.9	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1025	1027	TGC	27;26;26	T;G;C	27;26;26	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1348	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3077	23.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	342	342	T	14	T	14	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1348	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3077	23.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	648	650	GAC	26;25;25	G;A;C	26;25;25	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1348	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3077	23.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	924	926	TTA	13;14;14	T;T;A	13;14;14	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1348	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3077	23.3	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1107	1109	AAT	18;17;17	A;A;T	18;17;15	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	1348	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3077	23.3	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1894	1894	T	23	T	23	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	278	acrR_2	648	648	99.54	acrR_2.l6.c4.ctg.1	1055	13.9	1	SNP	p	R45C	0	.	.	133	135	CGC	349	351	CGC	21;21;21	C;G;C	21;21;21	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	334	acrS	663	663	98.64	acrS.l6.c4.ctg.1	996	17.5	0	.	p	.	0	L34F	NONSYN	100	102	CTC	267	269	TTC	16;15;15	T;T;C	15;15;15	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	334	acrS	663	663	98.64	acrS.l6.c4.ctg.1	996	17.5	0	.	p	.	0	E122G	NONSYN	364	366	GAG	531	533	GGG	19;19;19	G;G;G	17;19;19	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	422	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1284	17.4	0	.	p	.	0	V136L	NONSYN	406	408	GTT	652	654	CTT	25;23;23	C;T;T	25;23;23	.	adiY;adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1436	alaS	2631	2631	98.86	alaS.l6.c17.ctg.1	3149	24.4	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2150	2152	GCA	31;31;32	G;C;A	31;31;32	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1436	alaS	2631	2631	98.86	alaS.l6.c17.ctg.1	3149	24.4	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2411	2413	ACC	17;18;18	A;C;C	17;18;18	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	1436	alaS	2631	2631	98.86	alaS.l6.c17.ctg.1	3149	24.4	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2720	2722	GCC	21;21;21	G;C;C	21;19;21	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	682	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2198	16.2	0	.	p	.	0	G37A	NONSYN	109	111	GGT	167	169	GCT	6;6;7	G;C;T	6;6;7	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	682	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2198	16.2	0	.	p	.	0	D77E	NONSYN	229	231	GAT	287	289	GAG	3;3;4	G;A;G	3;3;4	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	682	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2198	16.2	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	323	325	TGC	7;7;8	T;G;C	7;7;8	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	682	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2198	16.2	0	.	p	.	0	I150V	NONSYN	448	450	ATT	506	508	GTT	14;13;15	G;T;T	14;13;14	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	682	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2198	16.2	0	.	p	.	0	R200H	NONSYN	598	600	CGC	656	658	CAC	13;13;12	C;A;C	12;13;12	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	682	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2198	16.2	0	.	p	.	0	T295M	NONSYN	883	885	ACG	941	943	ATG	19;19;19	A;T;G	19;19;19	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	682	arnA_1	1983	1983	98.24	arnA_1.l6.c4.ctg.1	2198	16.2	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1937	1939	CGC	12;13;13	C;G;C	12;13;13	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	358	bacA	822	801	98.63	bacA.l15.c4.ctg.1	975	18.6	0	.	p	.	0	S221T	NONSYN	661	663	AGC	835	837	ACC	12;13;14	A;C;C	12;13;14	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	531	358	bacA	822	801	98.63	bacA.l15.c4.ctg.1	975	18.6	0	.	p	.	0	P225S	NONSYN	673	675	CCG	847	849	TCG	13;14;14	T;C;G	13;14;14	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	332	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1066	16.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	508	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1707	15.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1408	1410	AAA	4;4;4	A;A;A	3;4;4	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	508	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1707	15.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1420	1422	GAG	5;6;6	G;A;G	5;6;6	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	508	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1707	15.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1426	1428	CAC	7;7;8	C;A;C	7;7;8	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	508	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1707	15.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1480	1482	GAG	13;13;12	G;A;G	13;13;12	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	706	cpxA	1374	1374	98.91	cpxA.l6.c4.ctg.1	1830	20.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	410	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1253	17.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	430	cysB	975	975	99.28	cysB.l6.c4.ctg.1	1434	15.9	0	.	p	.	0	A146T	NONSYN	436	438	GCT	662	664	ACT	19;21;21	A;C;T	19;21;21	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	278	dfrA1_1	474	474	100.0	dfrA1_1.l15.c30.ctg.1	978	15.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1;dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	532	emrA	1173	1173	98.29	emrA.l15.c4.ctg.1	1585	17.4	0	.	p	.	0	I219V	NONSYN	655	657	ATC	968	970	GTC	13;13;12	G;T;C	13;13;12	.	emrA;EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	876	emrB	1539	1539	99.74	emrB.l15.c30.ctg.1	2059	22.7	0	.	p	.	0	E197K	NONSYN	589	591	GAA	839	841	AAA	24;24;24	A;A;A	23;24;23	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	534	emrD	1191	1191	98.4	emrD.l6.c30.ctg.1	1428	19.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	811	813	AGC	10;10;10	A;G;C	10;10;10	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	456	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1413	16.2	0	.	p	.	0	K176R	NONSYN	526	528	AAG	826	828	AGG	13;13;13	A;G;G	13;13;13	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	456	emrK	1056	1056	98.2	emrK.l15.c17.ctg.1	1413	16.2	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1216	1218	GAC	7;7;6	G;A;C	7;7;6	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	302	emrR	531	531	100.0	emrR.l15.c4.ctg.1	985	15.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.;emrR
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	766	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2046	19.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	286	evgA	615	615	99.19	evgA.l15.c30.ctg.1	1109	13.7	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	440	442	CTG	13;14;14	C;T,C;G	13;13,1;14	.	EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.;evgA
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	T38I	NONSYN	112	114	ACA	5	7	ATA	2;2;3	A;T;A	2;2;3	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	L42V	NONSYN	124	126	CTA	17	19	GTA	8;8;8	G;T;A	8;8;8	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	A93T	NONSYN	277	279	GCG	170	172	ACG	16;17;18	A;C;G	16;17;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	A114E	NONSYN	340	342	GCA	233	235	GAA	12;12;11	G;A;A	12;12;11	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	T127A	NONSYN	379	381	ACT	272	274	GCT	15;15;15	G;C;T	15;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	N133D	NONSYN	397	399	AAT	290	292	GAT	15;17;18	G;A;T	15;17;18	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	P162S	NONSYN	484	486	CCA	377	379	TCA	14;14;14	T;C;A	14;14;14	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	506	508	CAG	7;7;7	C;A;G	7;7;7	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	I251V	NONSYN	751	753	ATT	644	646	GTT	14;14;14	G;T;T	14;14;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	N303D	NONSYN	907	909	AAT	800	802	GAT	6;7;6	G;A;T	6;7;6	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	968	970	AAT	5;5;5	A;A;T	5;5;5	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	993	96.58	evgS.l15.c30.ctg.1	995	14.9	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	989	991	TTA	1;1;1	T;T;A	1;1;1	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	196	198	AAA	9;9;9	A;A;A	8;9;9	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	931	933	CAT	14;15;17	C;A;T	14;15;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	985	987	CAT	18;17;15	C;A;T	17;17;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	1003	1005	AGA	19;18;18	A;G;A	19;18;17	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	1018	1020	AAT	19;19;19	A;A;T	19;19;19	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	1165	1167	TCC	11;10;12	T;C;C	11;10;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	1330	1332	ATT	12;12;13	A;T;T	12;12;13	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	1351	1353	GAT	15;15;15	G;A;T	15;15;15	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	1465	1467	GTT	20;21;21	G;T;T	20;21;21	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	2490	97.87	evgS.l15.c30.ctg.2	2680	19.2	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	1750	1752	CAC	11;11;12	C;A;C	11;11;12	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	513	1316	evgS	3594	120	99.17	evgS.l15.c30.ctg.3	325	10.6	0	.	p	.	0	T38I	NONSYN	112	114	ACA	317	319	ATA	5;5;4	A;T;A	5;5;4	.	EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.;evgS
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	394	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1213	16.7	1	SNP	p	P64H	0	.	.	190	192	CCA	367	369	CCA	27;27;27	C;C;A	27;26;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	394	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1213	16.7	1	SNP	p	P64S	0	.	.	190	192	CCA	367	369	CCA	27;27;27	C;C;A	27;26;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	394	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1213	16.7	1	SNP	p	P64L	0	.	.	190	192	CCA	367	369	CCA	27;27;27	C;C;A	27;26;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	394	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1213	16.7	1	SNP	p	P64A	0	.	.	190	192	CCA	367	369	CCA	27;27;27	C;C;A	27;26;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	394	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1213	16.7	1	SNP	p	P64R	0	.	.	190	192	CCA	367	369	CCA	27;27;27	C;C;A	27;26;26	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	292	gadE	528	528	100.0	gadE.l15.c30.ctg.1	1076	14.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	142	97.18	gadW.l15.c4.ctg.1	142	10.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	167	93.41	gadW.l15.c4.ctg.2	168	6.4	0	.	p	.	0	D100E	NONSYN	298	300	GAC	8	10	GAA	1;1;1	G;A;A	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	167	93.41	gadW.l15.c4.ctg.2	168	6.4	0	.	p	.	0	P101S	NONSYN	301	303	CCC	11	13	TCC	1;1;1	T;C;C	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	167	93.41	gadW.l15.c4.ctg.2	168	6.4	0	.	p	.	0	R102G	NONSYN	304	306	CGG	14	16	GGG	1;1;1	G;G;G	1;1;1	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	58	gadW	729	167	93.41	gadW.l15.c4.ctg.2	168	6.4	0	.	p	.	0	K110N	NONSYN	328	330	AAA	38	40	AAT	3;3;3	A;A;T	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	304	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1098	14.4	0	.	p	.	0	F53L	NONSYN	157	159	TTC	406	408	TTA	14;13;13	T;T;A	14;13;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	304	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1098	14.4	0	.	p	.	0	V79I	NONSYN	235	237	GTT	484	486	ATT	14;14;13	A;T;T	14;14;13	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	304	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1098	14.4	0	.	p	.	0	R246G	NONSYN	736	738	AGA	985	987	GGA	10;10;10	G;G;A	10;10;10	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	304	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1098	14.4	0	.	p	.	0	S248P	NONSYN	742	744	TCG	991	993	CCG	11;11;11	C;C;G	11;11;11	.	gadX;GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1460	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3103	25.0	1	SNP	p	D87Y	1	D87Y	NONSYN	259	261	GAC	498	500	TAC	28;27;27	T;A,T;C	28;24,1;25	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1460	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3103	25.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2271	2273	GAA	16;17;17	G;A;A	16;17;16	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1460	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3103	25.0	1	SNP	p	S83W	0	.	.	247	249	TCG	486	488	TCG	28;28;28	T;C;G	27;27;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1460	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3103	25.0	1	SNP	p	S83L	0	.	.	247	249	TCG	486	488	TCG	28;28;28	T;C;G	27;27;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	1460	gyrA_7	2628	2628	98.67	gyrA_7.l15.c4.ctg.1	3103	25.0	1	SNP	p	S83I	0	.	.	247	249	TCG	486	488	TCG	28;28;28	T;C;G	27;27;28	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2908	21.8	1	SNP	p	R136E	0	.	.	406	408	CGC	703	705	CGC	28;28;26	C;G;C	27;28;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2908	21.8	1	SNP	p	R136C	0	.	.	406	408	CGC	703	705	CGC	28;28;26	C;G;C	27;28;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2908	21.8	1	SNP	p	R136L	0	.	.	406	408	CGC	703	705	CGC	28;28;26	C;G;C	27;28;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2908	21.8	1	SNP	p	R136I	0	.	.	406	408	CGC	703	705	CGC	28;28;26	C;G;C	27;28;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2908	21.8	1	SNP	p	R136S	0	.	.	406	408	CGC	703	705	CGC	28;28;26	C;G;C	27;28;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2908	21.8	1	SNP	p	R136H	0	.	.	406	408	CGC	703	705	CGC	28;28;26	C;G;C	27;28;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	1192	gyrB_1	2415	2415	99.05	gyrB_1.l6.c30.ctg.1	2908	21.8	1	SNP	p	R136G	0	.	.	406	408	CGC	703	705	CGC	28;28;26	C;G;C	27;28;26	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	258	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1003	13.2	0	.	p	.	0	A72P	NONSYN	214	216	GCG	407	409	CCG	22;21;20	C;C;G	22;21;20	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	258	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1003	13.2	0	.	p	.	0	T123A	NONSYN	367	369	ACC	560	562	GCC	13;13;12	G;C;C	11;13;12	.	kdpE;kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	522	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1470	19.0	0	.	p	.	0	P9S	NONSYN	25	27	CCA	262	264	TCA	17;17;18	T;C;A	17;17;18	.	leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.;leuO
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	210	marA	384	384	99.74	marA.l15.c30.ctg.1	788	13.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	541	543	AGC	10;10;10	A;G;C	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	643	645	CAT	4;4;4	C;A;T	4;4;4	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	V45E	0	.	.	133	135	GTG	367	369	GTG	21;20;20	G;T;G	20;20;20	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	I49S	0	.	.	145	147	ATC	379	381	ATC	13;13;14	A;T;C	13;13;14	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	A70T	0	.	.	208	210	GCA	442	444	GCA	11;11;11	G;C;A	11;11;11	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	R73C	0	.	.	217	219	CGT	451	453	CGT	11;10;10	C;G;T	11;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	R73S	0	.	.	217	219	CGT	451	453	CGT	11;10;10	C;G;T	11;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	R77L	0	.	.	229	231	CGC	463	465	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	R77C	0	.	.	229	231	CGC	463	465	CGC	8;8;8	C;G;C	8;8;8	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	L78M	0	.	.	232	234	CTG	466	468	CTG	7;7;7	C;T;G	7;7;7	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	R94S	0	.	.	280	282	CGC	514	516	CGC	9;9;9	C;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	R94H	0	.	.	280	282	CGC	514	516	CGC	9;9;9	C;G;C	9;9;9	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	120	marR	435	435	97.7	marR.l15.c4.ctg.1	806	7.7	1	SNP	p	V96E	0	.	.	286	288	GTA	520	522	GTA	10;10;10	G;T;A	10;10;10	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	S7F	NONSYN	19	21	TCC	20	22	TTC	3;3;3	T;T;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	R36I	NONSYN	106	108	AGG	107	109	ATC	5;5;5	A;T;C	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	E42A	NONSYN	124	126	GAA	125	127	GCC	3;3;3	G;C;C	3;3;3	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	N43V	NONSYN	127	129	AAT	128	130	GTG	3;3;4	G;T;G	3;3;4	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	E52D	NONSYN	154	156	GAG	155	157	GAT	5;5;5	G;A;T	5;5;5	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	N59T	NONSYN	175	177	AAC	176	178	ACC	7;8;8	A;C;C	7;8;8	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	I68L	NONSYN	202	204	ATA	203	205	TTA	11;11;11	T;T;A	11;11;11	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	344	346	CAG	20;20;20	C;A;G	20;20;20	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	D128A	NONSYN	382	384	GAC	383	385	GCC	20;23;23	G;C;C	20;23;23	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	S163A	NONSYN	487	489	TCG	488	490	GCG	14;15;16	G;C;G	14;15;16	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	L231V	NONSYN	691	693	CTT	692	694	GTT	21;22;22	G,T;T;T	18,2;21;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	404	mdfA	1233	1233	97.0	mdfA.l15.c4.ctg.1	1444	14.7	0	.	p	.	0	R285fs	FSHIFT	853	853	C	854	854	C	14	C	14	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	422	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1620	13.8	0	.	p	.	0	V12trunc	TRUNC	34	34	G	220	220	G	18	G	18	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	422	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1620	13.8	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	277	279	CAG	7;7;6	C;A;G	7;7;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	422	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1620	13.8	0	.	p	.	0	T83I	NONSYN	247	249	ACC	427	429	ATC	11;10;10	A;T;C	11;10;10	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	422	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1620	13.8	0	.	p	.	0	I99M	NONSYN	295	297	ATA	475	477	ATG	5;5;6	A;T;G	5;5;6	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	422	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1620	13.8	0	.	p	.	0	A130T	NONSYN	388	390	GCC	568	570	ACC	17;17;17	A;C;C	17;17;17	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	422	mdtA	1248	1248	97.36	mdtA.l6.c4.ctg.1	1620	13.8	0	.	p	.	0	P257T	NONSYN	769	771	CCG	949	951	ACG	16;16;17	A;C;G	16;16;17	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1496	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3548	22.6	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	1990	1992	ACC	20;19;21	A;C;C	19;19;21	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1496	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3548	22.6	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2383	2385	CAA	14;15;15	C;A;A	14;15;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1496	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3548	22.6	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2551	2553	ATT	18;18;18	A;T;T	18;18;18	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1496	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3548	22.6	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2635	2637	GTT	14;15;15	G;T;T	14;15;15	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1496	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3548	22.6	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2743	2745	GAG	19;17;16	G;A;G	18;16;16	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1496	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3548	22.6	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	2971	2973	ATG	15;16;17	A;T;G	15;16;17	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	1496	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3548	22.6	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3106	3108	GAT	16;16;17	G;A;T	15;16;17	.	mdtB;MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1298	mdtC	3078	3074	98.63	mdtC.l6.c4.ctg.1	3183	21.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	245	247	ATG	11;11;12	A;T;G	11;11;12	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1298	mdtC	3078	3074	98.63	mdtC.l6.c4.ctg.1	3183	21.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	731	733	ATC	17;17;16	A;T;C	17;17;16	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1298	mdtC	3078	3074	98.63	mdtC.l6.c4.ctg.1	3183	21.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3047	3049	CAC	5;5;5	C;A;C	5;5;5	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	531	1298	mdtC	3078	3074	98.63	mdtC.l6.c4.ctg.1	3183	21.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3050	3052	CTC	5;5;6	C;T;C	5;5;6	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	576	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1905	16.1	0	.	p	.	0	D3E	NONSYN	7	9	GAT	234	236	GAA	5;5;5	G;A;A	5;5;5	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	576	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1905	16.1	0	.	p	.	0	T226A	NONSYN	676	678	ACG	903	905	GCG	21;25;26	G;C;G	21;24;26	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	576	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1905	16.1	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1245	1247	ATC	28;28;28	A;T;C	27;28;28	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	576	mdtD	1416	1416	98.38	mdtD.l6.c4.ctg.1	1905	16.1	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1548	1550	TTT	19;19;19	T,G;T;T	18,1;19;19	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	644	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1680	20.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1672	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3616	24.7	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1114	1116	ACC	17;17;16	A;C,A;C	17;15,1;16	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	1672	mdtF	3114	3114	98.52	mdtF.l15.c30.ctg.1	3616	24.7	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2356	2358	GAC	31;31;31	G,A;A;C,G	30,1;29;28,1	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	626	mdtG	1227	1047	99.33	mdtG.l15.c17.ctg.1	1606	17.0	0	.	p	.	0	V200I	NONSYN	598	600	GTC	759	761	ATC	25;24;24	A;T;C	24;24;24	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	626	mdtG	1227	140	100.0	mdtG.l15.c17.ctg.2	149	18.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	454	mdtH	1209	1201	98.17	mdtH.l15.c17.ctg.1	1450	16.1	0	.	p	.	0	G134C	NONSYN	400	402	GGT	649	651	TGT	26;26;26	T;G;T	26;26;26	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	454	mdtH	1209	1201	98.17	mdtH.l15.c17.ctg.1	1450	16.1	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1219	1221	TTG	14;14;13	T;T;G	14;14;13	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	531	454	mdtH	1209	1201	98.17	mdtH.l15.c17.ctg.1	1450	16.1	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1429	1431	ACG	2;2;2	A;C;G	2;2;2	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	562	mdtL	1176	1176	98.38	mdtL.l6.c4.ctg.1	1720	17.6	0	.	p	.	0	A185S	NONSYN	553	555	GCC	785	787	TCC	16;16;17	T;C;C	16;16;17	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	500	mdtN	1032	1032	98.02	mdtN.l15.c4.ctg.1	1601	16.6	0	.	p	.	0	V119I	NONSYN	355	357	GTT	584	586	ATT	13;13;13	A;T;T	13;13;13	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.;mdtN
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	V11M	NONSYN	31	33	GTG	192	194	ATG	10;10;10	A;T;G	10;10;10	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	T33I	NONSYN	97	99	ACC	258	260	ATC	13;13;12	A;T;C	13;13;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	C116R	NONSYN	346	348	TGC	507	509	CGC	24;24;25	C;G;C	24;24;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	N238S	NONSYN	712	714	AAC	873	875	AGC	26;25;24	A;G;C	26;25;24	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1074	1076	GTG	18;18;19	G;T;G	18;18;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1137	1139	AAC	12;12;12	A;A;C	12;12;12	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1182	1184	GTC	17;18;18	G;T;C	17;18;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1212	1214	ATA	30;30;28	A;T;A	29;30;28	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1320	1322	TCT	19;20;21	T;C;T	19;20;21	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1707	1709	GCG	21;19;19	G;C;G	21;19;19	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	1000	mdtO	2052	2052	98.1	mdtO.l6.c4.ctg.1	2538	21.0	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1920	1922	ATC	19;19;18	A;T;C	19;19;18	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	S129A	NONSYN	385	387	TCA	570	572	GCG	22;22;22	G;C;G	21;22;22	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	A187T	NONSYN	559	561	GCC	744	746	ACC	18;20;20	A;C;C	18;20;19	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	H211R	NONSYN	631	633	CAC	816	818	CGC	22;22;23	C;G;C	22;22;23	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	V250A	NONSYN	748	750	GTT	933	935	GCT	15;16;15	G;C;T	15;16;15	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1017	1019	AAA	7;7;7	A;A;A	7;7;7	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1035	1037	CGA	8;8;9	C;G;A	8;8;8	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1200	1202	GCC	15;15;13	G;C;C	15;15;13	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1212	1214	GAT	14;13;13	G;A;T	14;13;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	554	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	1814	16.0	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1629	1631	GCT	14;13;13	G;C;T	14;13;12	.	mdtP;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1564	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3952	21.2	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1586	1588	AAG	14;15;15	A;A;G	14;15;15	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	1564	mfd	3447	3447	99.16	mfd.l15.c30.ctg.1	3952	21.2	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2663	2665	CTG	20;19;20	C;T;G	20;19;20	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	114	mgrB	144	144	100.0	mgrB.l15.c4.ctg.3	167	18.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB;mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	940	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1889	25.9	0	.	p	.	0	S278N	NONSYN	832	834	AGC	912	914	AAC	21;21;21	A;A;C	21;21;21	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	940	msbA	1749	1749	98.68	msbA.l15.c30.ctg.1	1889	25.9	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1458	1460	ATA	26;27;27	A;T;A	26;27;27	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	682	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1806	20.2	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1375	1377	GAT	37;36;36	G;A;T	36;36;36	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	682	murA_12	1260	1260	98.49	murA_12.l15.c30.ctg.1	1806	20.2	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1378	1380	CTG	36;36;34	C;T;G	36;36;34	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	379	98.94	nfsA.l15.c30.ctg.1	822	12.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	230	232	TGT	17;17;17	T;G;T	17;17;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	379	98.94	nfsA.l15.c30.ctg.1	822	12.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	500	502	ACC	18;17;18	A;C;C	18;17;17	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	379	98.94	nfsA.l15.c30.ctg.1	822	12.6	1	SNP	p	R15C	0	.	.	43	45	CGC	194	196	CGC	28;28;28	C;G;C	28;28;28	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	379	98.94	nfsA.l15.c30.ctg.1	822	12.6	1	SNP	p	S33R	0	.	.	97	99	AGC	248	250	AGC	10;9;9	A;G;C	10;9;9	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	317	98.74	nfsA.l15.c30.ctg.2	569	13.3	0	.	p	.	0	N134H	NONSYN	400	402	AAT	282	284	CAT	16;16;16	C,A;A;T	1,11;15;14	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	317	98.74	nfsA.l15.c30.ctg.2	569	13.3	0	.	p	.	0	G187D	NONSYN	559	561	GGC	441	443	GAC	18;17;18	G;A;C	18;17;18	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	317	98.74	nfsA.l15.c30.ctg.2	569	13.3	1	SNP	p	G131D	0	.	.	391	393	GGC	273	275	GGC	13;13;13	G;G;C	13;13;11	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	317	98.74	nfsA.l15.c30.ctg.2	569	13.3	1	SNP	p	R203L	0	.	.	607	609	CGT	489	491	CGT	21;21;22	C;G;T	21;20;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	641	364	nfsA	723	317	98.74	nfsA.l15.c30.ctg.2	569	13.3	1	SNP	p	R203C	0	.	.	607	609	CGT	489	491	CGT	21;21;22	C;G;T	21;20;22	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	608	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1512	21.2	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1152	1154	GAG	30;29;29	G;A;G	30;29;29	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	608	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1512	21.2	1	SNP	p	G141E	0	.	.	421	423	GGT	639	641	GGT	29;30;31	G;G;T	29;30;31	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	608	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1512	21.2	1	SNP	p	G141D	0	.	.	421	423	GGT	639	641	GGT	29;30;31	G;G;T	29;30;31	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	608	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1512	21.2	1	SNP	p	R154A	0	.	.	460	462	CGT	678	680	CGT	24;24;27	C;G;T	24;24;26	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	608	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1512	21.2	1	SNP	p	R154D	0	.	.	460	462	CGT	678	680	CGT	24;24;27	C;G;T	24;24;26	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1282	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2777	24.7	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1859	1861	GTG	29;29;29	G;T;G	29;29;29	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1282	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2777	24.7	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1886	1888	TCG	27;27;28	T;C;G	25;24;26	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1282	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2777	24.7	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2501	2503	AAC	17;17;17	A;A;C	17;17;16	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1282	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2777	24.7	1	SNP	p	A85T	0	.	.	253	255	GCG	515	517	GCG	36;36;36	G;C;G	35;35;35	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1282	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2777	24.7	1	SNP	p	D111H	0	.	.	331	333	GAT	593	595	GAT	31;31;31	G;A;T	31;31;31	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	1282	parC_2	2259	2259	99.2	parC_2.l15.c4.ctg.1	2777	24.7	1	SNP	p	S129P	0	.	.	385	387	TCC	647	649	TCC	32;32;32	T;C;C	32;32;30	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	523	822	parE_1	1893	1893	97.43	parE_1.l15.c4.ctg.1	2053	19.6	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1278	1280	AAC	18;20;20	A;A;C	18;20;20	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	523	822	parE_1	1893	1893	97.43	parE_1.l15.c4.ctg.1	2053	19.6	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1287	1289	GAT	26;27;26	G;A;T	26;27;26	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	523	822	parE_1	1893	149	98.66	parE_1.l15.c4.ctg.2	199	12.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	792	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1997	21.2	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	932	934	CAG	30;29;28	C;A;G	30;29;28	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	792	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1997	21.2	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1406	1408	GAT	23;23;23	G;A;T	23;22;23	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	V146F	0	.	.	436	438	GTT	732	734	GTT	31;31;32	G;T;T	30;31;32	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1833	1835	CAG	24;26;26	C;A;G	24;26;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1833	1835	CAG	24;26;26	C;A;G	24;26;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1872	1874	CAC	27;27;26	C;A;C	27;27;26	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1881	1883	CGT	28;27;27	C;G;T	28;27;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1881	1883	CGT	28;27;27	C;G;T	28;27;27	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1887	1889	TCC	27;24;25	T;C;C	26;24;25	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1893	1895	CTC	26;24;23	C;T;C	26;24;23	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1983	1985	ACC	36;35;35	A;C;C	36;35;35	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1986	1988	CCT	35;35;33	C;C;T	35;35;33	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	2222	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4511	26.2	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2355	2357	CGT	28;29;29	C;G;T	27;29;29	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	.	n	.	0	A226G	SNP	226	226	A	374	374	G	191	G	191	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	1	SNP	n	A794T	0	.	.	794	794	A	942	942	A	154	A	150	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	1	SNP	n	A794G	0	.	.	794	794	A	942	942	A	154	A	150	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	1	SNP	n	G926T	0	.	.	926	926	G	1074	1074	G	164	G	164	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	1	SNP	n	G926C	0	.	.	926	926	G	1074	1074	G	164	G	164	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	1	SNP	n	G926A	0	.	.	926	926	G	1074	1074	G	164	G	164	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	1	SNP	n	A1519C	0	.	.	1519	1519	A	1667	1667	A	146	A	144	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	1	SNP	n	A1519G	0	.	.	1519	1519	A	1667	1667	A	146	A	144	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	1	SNP	n	A1519T	0	.	.	1519	1519	A	1667	1667	A	146	A	144	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	G1006C	.	1006	1006	G	1154	1154	G	191	G,C	127,62	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	A79G	.	79	79	A	227	227	A	167	A,G	124,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	C719T	.	719	719	C	867	867	C	160	C,T	98,60	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	T273A	.	273	273	T	421	421	T	160	T,A	118,41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	T1010C	.	1010	1010	T	1158	1158	T	180	T,C	119,60	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	C1038T	.	1038	1038	C	1186	1186	C	166	C,T	106,60	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	C183T	.	183	183	C	331	331	C	168	C,T	123,44	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	T90C	.	90	90	T	238	238	T	174	T,C	128,44	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	A250T	.	250	250	A	398	398	A	169	A,T	126,41	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	G474A	.	474	474	G	622	622	G	190	G,A	145,43	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	A253T	.	253	253	A	401	401	A	173	A,T	130,40	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	C194T	.	194	194	C	342	342	C	178	C,T	148,27	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	691	5950	rrsB+	1542	1542	99.94	rrsB+.l15.c17.ctg.1	1703	173.5	0	HET	.	.	.	G1002A,C	.	1002	1002	G	1150	1150	G	187	G,A,C	122,63,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	398	sat_1	525	525	100.0	sat_1.l6.c4.ctg.1	1168	18.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	286	soxR	465	465	100.0	soxR.l6.c4.ctg.1	903	16.7	1	SNP	p	R20H	0	.	.	58	60	CGC	278	280	CGC	27;25;25	C;G;C	27;24;25	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	286	soxR	465	465	100.0	soxR.l6.c4.ctg.1	903	16.7	1	SNP	p	G121D	0	.	.	361	363	GGT	581	583	GGT	25;25;27	G;G;T	25;25;27	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	186	soxS_1	324	324	99.69	soxS_1.l15.c4.ctg.1	854	11.4	1	SNP	p	A12S	0	.	.	34	36	GCA	344	346	GCA	13;12;12	G;C;A	13;12;12	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	539	3288	APH_3____Ib+	804	804	99.88	APH_3____Ib+.l15.c30.ctg.1	1500	117.4	0	.	p	.	0	P121Q	NONSYN	361	363	CCG	720	722	CAG	191;190;190	C;A,G;G,T	190;186,1;187,1	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
strB.manually_added_NC_009345_WP_000480968.1_7459_8295	strB.manually_added_NC_009345_WP_000480968.1_7459_8295	1	0	27	3352	APH_6__Id+	837	837	100.0	APH_6__Id+.l15.c4.ctg.1	1434	124.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.3000412.AY055428.20268_21084.552	sul2.3000412.AY055428.20268_21084.552	1	0	27	2586	sul2	816	816	100.0	sul2.l15.c30.ctg.1	1482	93.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Sul2 is a sulfonamide resistant dihydropteroate synthase of Gram-negative bacteria, usually found on small plasmids.;sul2
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	27	3828	tetA	1200	1200	100.0	tetA.l15.c4.ctg.1	1827	112.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	27	2236	tetR	651	651	100.0	tetR.l15.c4.ctg.1	1194	100.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	870	tolC	1488	1488	98.72	tolC.l15.c30.ctg.1	2115	22.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
